Caffeine can make these medications less effective at fighting infections. Theochron (theophylline) is a medication used to manage severe asthma and chronic obstructive pulmonary disease (COPD).

DelveInsight's“Bullous Pemphigoid Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bullous Pemphigoid, historical and forecasted epidemiology as ...

Ohtuvayre (ensifentrine) for COPD: Approved June 26, the inhaled medication is the first new type of maintenance COPD drug in over a decade ... First approved in 2020, the oral medication can ...

In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...

The year 2025 has dawned with a new respiratory illness-- caused ... chronic respiratory conditions like asthma or chronic obstructive pulmonary disease (COPD). Infants, children under the age ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

But it is only now being detected more via a test that costs about Rs 15,000 to Rs 20,000.' 'The HMPV virus typically causes ...

India has reported over 15 cases of HMPV. Meanwhile, China attributed the rise in cases to improved detection methods in ...

The FDA had this to say: "Today's approval of the first generic for one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD ... In a new white paper ...